Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2011 (2011), Article ID 929102, 5 pages
http://dx.doi.org/10.4061/2011/929102
Research Article

An Intron 7 Polymorphism in APP Affects the Age of Onset of Dementia in Down Syndrome

1Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College London, London SE1 1UL, UK
2Genomics Centre, Franklin-Wilkins Building, King's College London, London SE1 9NH, UK
3Department of Psychiatry, Royal Victoria Infirmary, Newcastle Upon Tyne NE1 4LP, UK
4Learning Disability Medical Directorate, Northgate Hospital, Morpeth, Northumberland NE61 3PB, UK

Received 23 August 2010; Revised 21 October 2010; Accepted 6 December 2010

Academic Editor: Lindsay A. Farrer

Copyright © 2011 Emma L. Jones et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. B. Hook, “Rates and Down's syndrome in live births and at midtrimester amniocentesis,” Lancet, vol. 1, no. 8072, pp. 1053–1054, 1978. View at Google Scholar · View at Scopus
  2. H. M. Wisniewski, W. Silverman, and J. Wegiel, “Ageing, Alzheimer disease and mental retardation,” Journal of Intellectual Disability Research, vol. 38, no. 3, pp. 233–239, 1994. View at Google Scholar · View at Scopus
  3. R. D. Terry, L. A. Hansen, and R. DeTeresa, “Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles,” Journal of Neuropathology and Experimental Neurology, vol. 46, no. 3, pp. 262–268, 1987. View at Google Scholar
  4. V. P. Prasher and V. H. R. Krishnan, “Age of onset and duration of dementia in people with Down syndrome: integration of 98 reported cases in the literature,” International Journal of Geriatric Psychiatry, vol. 8, no. 11, pp. 915–922, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Holland, J. Hon, F. A. Huppert, F. Stevens, and P. Watson, “Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome,” British Journal of Psychiatry, vol. 172, pp. 493–498, 1998. View at Google Scholar · View at Scopus
  6. B. Rumble, R. Retallack, C. Hilbich et al., “Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease,” New England Journal of Medicine, vol. 320, no. 22, pp. 1446–1452, 1989. View at Google Scholar · View at Scopus
  7. A. Rovelet-Lecrux, D. Hannequin, G. Raux et al., “APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy,” Nature Genetics, vol. 38, no. 1, pp. 24–26, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. K. Sleegers, N. Brouwers, I. Gijselinck et al., “APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy,” Brain, vol. 129, no. 11, pp. 2977–2983, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. L. Cabrejo, L. Guyant-Maréchal, A. Laquerrière et al., “Phenotype associated with APP duplication in five families,” Brain, vol. 129, no. 11, pp. 2966–2976, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. K. Kasuga, T. Shimohata, A. Nishimura et al., “Identification of independent APP locus duplication in Japanese patients with early-onset Alzheimer disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 80, no. 9, pp. 1050–1052, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. K. Beyreuther, P. Pollwein, G. Multhaup et al., “Regulation and expression of the Alzheimer's β/A4 amyloid protein precursor in health, disease, and Down's syndrome,” Annals of the New York Academy of Sciences, vol. 695, pp. 91–102, 1993. View at Publisher · View at Google Scholar · View at Scopus
  12. E. W. Wolvetang, O. M. Bradfield, M. Tymms et al., “The chromosome 21 transcription factor ETS2 transactivates the β-APP promoter: implications for Down syndrome,” Biochimica et Biophysica Acta - Gene Structure and Expression, vol. 1628, no. 2, pp. 105–110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. R. E. Tanzi, A. I. McClatchey, E. D. Lamperti, L. Villa-Komaroff, J. F. Gusella, and R. L. Neve, “Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease,” Nature, vol. 331, no. 6156, pp. 528–530, 1988. View at Google Scholar · View at Scopus
  14. T. Matsui, M. Ingelsson, H. Fukumoto et al., “Expression of APP pathway mRNAs and proteins in Alzheimer's disease,” Brain Research, vol. 1161, no. 1, pp. 116–123, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S. A. Johnson, T. McNeill, B. Cordell, and C. B. Finch, “Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease,” Science, vol. 248, no. 4957, pp. 854–857, 1990. View at Google Scholar · View at Scopus
  16. L. S. Higgins, R. Catalano, D. Quon, and B. Cordell, “Transgenic mice expressing human β-APP751, but not mice expressing β-APP695, display early Alzheimer's disease-like histopathology,” Annals of the New York Academy of Sciences, vol. 695, pp. 224–227, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Li, R. Perry, J. Wu et al., “Polymorphic tetranucleotide repeat site within intron 7 of the β-amyloid precursor protein gene and its lack of association with Alzheimer's disease,” Human Genetics, vol. 103, no. 1, pp. 86–89, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Margallo-Lana, C. M. Morris, A. M. Gibson et al., “Influence of the amyloid precursor protein locus on dementia in Down syndrome,” Neurology, vol. 62, no. 11, pp. 1996–1998, 2004. View at Google Scholar · View at Scopus
  19. V. Prasher, A. Farooq, and R. Holder, “The Adaptive Behaviour Dementia Questionnaire (ABDQ): screening questionnaire for dementia in Alzheimer's disease in adults with Down syndrome,” Research in Developmental Disabilities, vol. 25, no. 4, pp. 385–397, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. World Health Organisation, International Classification of Diseases, WHO, Geneva, Switzerland, 10th edition, 1992.
  21. R. Donev, A. Newall, J. Thome, and D. Sheer, “A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms,” Molecular Psychiatry, vol. 12, no. 7, pp. 681–690, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. C. A. Haiman, S. E. Hankinson, D. Spiegelman et al., “A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk,” International Journal of Cancer, vol. 87, no. 2, pp. 204–210, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Shiroeda, T. Tahara, T. Shibata et al., “Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases,” International Journal of Molecular Medicine, vol. 26, no. 5, pp. 707–711, 2010. View at Publisher · View at Google Scholar
  24. M. Barrachina, E. Dalfó, B. Puig et al., “Amyloid-β deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AβPP mRNA isoforms containing the Kunitz protease inhibitor,” Neurochemistry International, vol. 46, no. 3, pp. 253–260, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. M. D. Caswell, SU. S. Mok, A. Henry et al., “The amyloid β-protein precursor of Alzheimer's disease is degraded extracellularly by a Kunitz protease inhibitor domain-sensitive trypsin-like serine protease in cultures of chick sympathetic neurons,” European Journal of Biochemistry, vol. 266, no. 2, pp. 509–516, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. R. D. Moir and R. E. Tanzi, “LRP-mediated clearance of Aβ is inhibited by KPI-containing isoforms of APP,” Current Alzheimer Research, vol. 2, no. 2, pp. 269–273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Van Broeckhoven, H. Backhovens, M. Cruts et al., “APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease,” Neuroscience Letters, vol. 169, no. 1-2, pp. 179–180, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Lewis, D. Beher, N. Cookson et al., “Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-β(42) peptide in vascular dementia,” Neuropathology and Applied Neurobiology, vol. 32, no. 2, pp. 103–118, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus